Наталья Владимировна Вавилова

Наталья Владимировна Вавилова

Auto-generated profile, based on publicly available information

Наталья Владимировна Вавилова

National Medical Research Center for Children’s Health

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2022 in Neuromuscular Diseases
Verified
Journal Article
Open access
PDF file
OKO. B. Kondakova
O. B. Kondakova
KKK. A. Kazakova
K. A. Kazakova
ALA. A. Lyalina
A. A. Lyalina
NLN. V. Lapshina
N. V. Lapshina
APA. A. Pushkov
A. A. Pushkov
KSKirill Savostyanov
Kirill Savostyanov
Aromatic L‑amino acid decarboxylase (AADC) deficiency is rare autosomal recessive neurometabolic disorder. It caused by generalized combined deficiency of serotonin, dopamine, norepinephrine and adrenaline. This disorder is characterized by muscular hypotonia, motor development delay, oculogyric crises and impairment of the autonomic nervous system.Laboratory diagnostic of AADC deficiency in Russian Federation includes determination of the concentration of 3‑O‑methyldophamine in dried blood spots by tandem mass spectrometry and molecular analysis of the DDC gene by Sanger sequencing or next generation sequencing.Therapy of AADC deficiency includes combination of drugs which increase the formation of dopamine, inhibit its reuptake and increase the residual activity of the enzyme. The first‑line drugs are selective dopamine agonists, monoamine oxidase inhibitors of type B and vitamin B6 supplements.We present the case of management and treatment of patients with AADC deficiency. The patient’s condition was improved by using of combination therapy with pyridoxal‑5‑phosphate, pramipexole and selegiline. Significant positive dynamics was achieved on pyridoxal‑5‑phosphate therapy for the first time.

20 August 2025 in L.O. Badalyan Neurological Journal
Verified
Journal Article
Open access
PDF file
NKNatalia A. Kharitonova
Natalia A. Kharitonova
МБМилана Александровна Басаргина
Милана Александровна Басаргина
НВНаталья Владимировна Вавилова
Наталья Владимировна Вавилова
ЕУЕвгения Владимировна Увакина
Евгения Владимировна Увакина
МНМарина Игоревна Нестерович
Марина Игоревна Нестерович
НХНаталия Александровна Харитонова
Наталия Александровна Харитонова
Pallister–Killian syndrome (tetrasomy 12p, mosaic isochromosome 12p syndrome) (OMIM#601803) is a rare genetic disease characterized by multiple developmental abnormalities and mental retardation. The frequency of occurrence is 5.1:1,000,000. Newborns with this syndrome are characterized by muscular hypotension, which causes children to experience breathing difficulty and feeding problems, craniofacial dysmorphic disorder: a “rough” face — a high protruding forehead, oblique eye slits with epicanthus, hypertelorism, a wide and flattened nose with turned-out nostrils, low-set and dysplastic ears, micrognathia, a wide mouth with an inverted lower lip, a thin upper lip in the shape of a Cupid’s bow. Most children have a high hairline, bilateral frontal-temporal alopecia, sparse eyebrows or eyelashes, and areas of hypopigmentation in the form of light spots or streaks. The neurological status most often shows a serious delay in the pace of speech, motor, and intellectual development, although a more “mild” course of the disease is described. Specific speech disorders are also characteristic. To verify the diagnosis, the child needs to examine the buccal epithelium or fibroblasts using FISH analysis. The prognosis of the disease is unfavourable. It is also aggravated by the presence of profound intellectual disability and the possible development of seizures. Currently, no specific treatment for patients has been developed. Depending on the clinical manifestations, therapy may include surgical correction of the identified congenital disorders. One of the important stages of managing patients with such a diagnosis is working with psychologists and educators to support the intellectual development and socialization of the child. The article presents a clinical case of managing a child with Pallister–Killian syndrome, as well as current views on the diagnosis of this disease.